457 related articles for article (PubMed ID: 19267156)
1. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
2. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
3. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
4. C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer.
Kato T; Kameoka S; Kimura T; Nishikawa T; Kobayashi M
Anticancer Res; 2002; 22(2B):1097-103. PubMed ID: 12168907
[TBL] [Abstract][Full Text] [Related]
5. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
6. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
[TBL] [Abstract][Full Text] [Related]
8. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
10. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors affecting local recurrence and survival for operable rectal cancers.
Kuru B; Camlibel M; Dinç S; Erdem E; Alagöl H
J Exp Clin Cancer Res; 2002 Sep; 21(3):329-35. PubMed ID: 12385573
[TBL] [Abstract][Full Text] [Related]
12. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
[TBL] [Abstract][Full Text] [Related]
14. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance].
Tejido Sánchez A; Sánchez Chapado M; Rosino Sánchez A; Passas Martínez J; Bethencourt Codes F; Ruiz Ramos P; Leiva Galvis O
Arch Esp Urol; 2002 Apr; 55(3):257-65. PubMed ID: 12068757
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.
Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T
Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
[TBL] [Abstract][Full Text] [Related]
18. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
19. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer].
Pan YS; Wan YL; Liu YC; Wang X; Wu T
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807
[TBL] [Abstract][Full Text] [Related]
20. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
